Presentations and Webcasts
GW Pharmaceuticals PLC at Piper Jaffray Europe Conference
Presented on 23rd June 2010; access to an online version does require registration
Access the webcast
GW Pharmaceuticals plc Interim Results
GW Pharmaceuticals plc hosted their Interim Results Presentation on Wednesday 20th May 2010.
Access the webcast
Phase IIb Cancer Pain Results - Analyst Presentation
GW Pharmaceuticals plc hosted the Phase IIb Cancer Pain Results Analyst Presentation on Tuesday 23rd March 2010. This is available for download as a combined audio and visual file.
Sativex Regulatory Update
GW Pharmaceuticals plc provided a regulatory update on 18th March 2010. To access webcast please click on the link below.
GW Pharmaceuticals plc Preliminary Results 2009
GW Pharmaceuticals plc hosted their Interim Results Presentation on Wednesday 25th November 2009. An audio webcast with synchronised PowerPoint presentation is available on demand.
GW Pharmaceuticals plc at Rodman & Renshaw Conference
Justin Gover, GW's Managing Director, is presenting at the Rodman & Renshaw Annual Global Investment Conference in New York on Thursday, September 10, 2009 at 3.40 pm EDT (8.40 pm BST). A live and recorded audio webcast with synchronised PowerPoint presentation is available on demand.
Access the presentation.
Access the webcast.
GW Pharmaceuticals plc Interim Results
GW Pharmaceuticals plc hosted their Interim Results Presentation on Wednesday 20th May 2009.
GW Phase III Spasticity Results - Analyst Presentation
GW Pharmaceuticals plc hosted todays Phase III Spasticity Results Analyst Presentation on Wednesday 11th March 2009 at 2:30pm.
GW Pharmaceuticals plc Preliminary Results
GW Pharmaceuticals plc hosted their Preliminary Results Presentation on Tuesday 18th Nov 2008. A PowerPoint presentation is available on demand.
GW Pharmaceuticals plc Interim Results
GW Pharmaceuticals plc hosted their Interim Results Presentation on Tuesday 19th June 2008. A PowerPoint presentation is available on demand.
Phase III MS Neuropathic Pain Trial Preliminary Results
GW Pharmaceuticals plc (AIM: GWP) announced preliminary results of a Phase III double-blind randomised placebo-controlled study of Sativex®. A conference call for analysts was held on Tuesday 8th April 2008.
GW Pharmaceuticals plc at BIO CEO & Investor Conference
Justin Gover, GW's Managing Director, presented at the BIO CEO & Investor Conference in New York on Tuesday 12th February 2008. A PowerPoint presentation has been made available on demand.